Literature DB >> 20123479

Screening for cognitive and social-emotional problems in individuals with PKU: tools for use in the metabolic clinic.

S Waisbren1, D A White.   

Abstract

Cognitive deficits, learning difficulties, and emotional problems occur at significantly higher rates in individuals with phenylketonuria (PKU) than in the general population. The relationship between elevated blood phenylalanine (Phe) levels and the severity of these problems often remain unrecognized. Children and adults with PKU require ongoing screening so that referrals to psychologists or psychiatrists familiar with metabolic disorders can be made when necessary for in-depth evaluation and treatment. To identify screening instruments that can be used by non-psychologists as well as psychologists, a group of 10 psychologists and a psychiatrist in the United States with expertise in neuropsychological assessment and PKU proposed a Uniform Assessment Method for PKU. Questionnaires were selected that reliably detect problems in adaptive behavior, executive function, and emotional well-being, representing the most vulnerable areas for individuals with PKU. These questionnaires are appropriate for individuals from infancy through adulthood, may be administered in less than 1h, have computerized scoring accessibility, have no practice effects, and are available in Spanish and English. In addition to assessing function at a single point in time, the screening measures may be administered at each clinic visit to assess changes in function related to metabolic status or treatment (e.g., Phe-restricted diet, food supplements). The following questionnaires comprise the Uniform Assessment Method for PKU: for 0-2 years, Adaptive Behavior Assessment System-Second Edition (ABAS-II); for 2-17 years, Behavior Rating Inventory of Executive Function (BRIEF) and Behavior Assessment System for Children-Second Edition (BASC-II); and for adults, BRIEF, Beck Anxiety Inventory (BAI), and Beck Depression Inventory-Second Edition (BDI-II). In addition to long-term monitoring of outcomes in PKU, this uniform screening approach facilitates PKU research, as data may be pooled across multiple clinics using a consistent battery of assessment measures. Copyright 2009 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20123479     DOI: 10.1016/j.ymgme.2009.10.006

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  8 in total

1.  Outcomes of phenylketonuria with relevance to follow-up.

Authors:  F J van Spronsen; A Bélanger-Quintana
Journal:  JIMD Rep       Date:  2011-06-22

2.  The role of integrated behavioral health in caring for patients with metabolic disorders.

Authors:  Neelkamal Soares; Roger W Apple; Shibani Kanungo
Journal:  Ann Transl Med       Date:  2018-12

3.  Neuropsychological outcomes in fatty acid oxidation disorders: 85 cases detected by newborn screening.

Authors:  Susan E Waisbren; Yuval Landau; Jenna Wilson; Jerry Vockley
Journal:  Dev Disabil Res Rev       Date:  2013

4.  Assessing Psychological Functioning in Metabolic Disorders: Validation of the Adaptive Behavior Assessment System, Second Edition (ABAS-II), and the Behavior Rating Inventory of Executive Function (BRIEF) for Identification of Individuals at Risk.

Authors:  Susan E Waisbren; Jianping He; Robert McCarter
Journal:  JIMD Rep       Date:  2015-02-25

5.  Management of adult patients with phenylketonuria: survey results from 24 countries.

Authors:  Friedrich K Trefz; Francjan J van Spronsen; Anita MacDonald; François Feillet; Ania C Muntau; Amaya Belanger-Quintana; Alberto Burlina; Mübeccel Demirkol; Marcello Giovannini; Christoph Gasteyger
Journal:  Eur J Pediatr       Date:  2014-12-06       Impact factor: 3.183

6.  Neuropsychiatric Symptoms in Inborn Errors of Metabolism: Incorporation of Genomic and Metabolomic Analysis into Therapeutics and Prevention.

Authors:  Lisa Pan; Jerry Vockley
Journal:  Curr Genet Med Rep       Date:  2013-01-08

7.  Socio-emotional Problems in Children with CDG.

Authors:  K F E van de Loo; L van Dongen; M Mohamed; T Gardeitchik; T W Kouwenberg; S B Wortmann; R J T Rodenburg; D J Lefeber; E Morava; C M Verhaak
Journal:  JIMD Rep       Date:  2013-06-04

8.  Executive function in adolescents with PKU and their siblings: Associations with biochemistry.

Authors:  R Sharman; K Sullivan; R Young; J McGill
Journal:  Mol Genet Metab Rep       Date:  2015-08-24
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.